Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Are you Dr. Yao?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Yao, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1998 - 2001
Baylor College of MedicineResidency, Internal Medicine, 1995 - 1998- Baylor College of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2021 - Present
TN State Medical License 2023 - 2027
GA State Medical License 2023 - 2026
OK State Medical License 2020 - 2026- OK State Medical License 2020 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
American Board of Internal Medicine Medical Oncology- Join now to see all
Publications & Presentations
PubMed
- 1 citationsHealth-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 study.Alberto Sobrero, Arvind Dasari, Jeneth Aquino, Sara Lonardi, Rocio Garcia-Carbonero
European Journal of Cancer. 2025-03-11 - Phase II trial of atezolizumab and bevacizumab for treatment of HPV-positive unresectable or metastatic squamous cell carcinoma of the anal canal.Van K Morris, Suyu Liu, Kangyu Lin, Haifeng Zhu, Seema Prasad
Clinical Cancer Research. 2025-02-28 - Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.Mahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, Ethan B Ludmir, Ashwathy B Pillai
The Oncologist. 2025-01-17
Press Mentions
10 Things to Know About Neuroendocrine TumorsFebruary 23rd, 2024- HUTCHMED Highlights Phase III FRESCO-2 MRCT Data Summary OfSeptember 8th, 2022
Chi-Med Highlights Presentation of Clinical Data from the Successful SANET-Ep Phase III Trial at ESMO Annual MeetingSeptember 25th, 2019- Join now to see all
